tiprankstipranks
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
US Market
CRVS
Corvus Pharmaceuticals
RESEARCH TOOLSreports
Want to see CRVS full AI Analyst Report?

Corvus Pharmaceuticals (CRVS) Income Statement

691 Followers

Corvus Pharmaceuticals Income Statement

Last quarter (Q4 2025), Corvus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Corvus Pharmaceuticals's net income was $-12.32M. See Corvus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -105.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 42.87M$ 27.55M$ 23.41M$ 32.56M$ 38.63M
Depreciation and Amortization
$ 105.00K$ 85.00K$ 151.00K$ 367.00K$ 460.00K
EBITDA
$ -42.97M$ -27.46M$ -23.26M$ -32.20M$ -38.17M
Operating Income
$ -42.97M$ -27.55M$ -23.41M$ -32.56M$ -38.63M
Other Income/Expenses
$ 27.69M$ -34.74M$ -3.62M$ -8.74M$ -4.61M
Pretax Income
$ -15.28M$ -62.29M$ -27.03M$ -41.31M$ -43.24M
Net Income
$ -15.28M$ -62.29M$ -27.03M$ -41.31M$ -43.24M
Per Share Metrics
Basic EPS
$ -0.19$ -1.02$ -0.56$ -0.89$ -1.03
Diluted EPS
$ -0.53$ -1.02$ -0.56$ -0.89$ -1.03
Weighted Average Shares Outstanding
 78.96M 60.99M 48.03M 46.55M 41.85M
Weighted Average Shares Outstanding (Diluted)
 79.74M 60.99M 48.03M 46.55M 41.85M
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History